Antisense Oligonucleotide Therapy Targeted Against ATXN3...

  • Main
  • 2020 / 08
  • Antisense Oligonucleotide Therapy Targeted Against ATXN3...

Antisense Oligonucleotide Therapy Targeted Against ATXN3 Improves Potassium Channel–Mediated Purkinje Neuron Dysfunction in Spinocerebellar Ataxia Type 3

Bushart, David D., Zalon, Annie J., Zhang, Hongjiu, Morrison, Logan M., Guan, Yuanfang, Paulson, Henry L., Shakkottai, Vikram G., McLoughlin, Hayley S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Cerebellum
DOI:
10.1007/s12311-020-01179-7
Date:
August, 2020
File:
PDF, 2.04 MB
2020
Conversion to is in progress
Conversion to is failed